Page 5 - ebook

Jintozet Tablet - 3 contents

A strong hyperlipidemia combo tablet

Dual Action Of Ezetimibe+Statin - In diabetic patients, the ezetimibe and
statin combination therapy lowered LDL-C
Ezetimibe Atorvastatin
and non-HDL-C more effectively than statin
monotherapy.

- A 12-week clinical trial was done in patients
with primary hypercholesterolemia who had
never had lipid therapy and did not have
The combination therapy of ezetimibe and statin
diabetes (n=628).
has a powerful effect on LDL-C lowering by
reducing both cholesterol production and
POLY PHARMA CORP.
absorption.
- Jintozet tablets performed strongly in LDL-C
reduction compared to atorvastatin single dose
in primary hypercholesterolemia patients.
2F.65-2, EUNPYEONG-RO(YEOKCHON-DONG)EUNPYEONG-GU,SEOUL ,KOREA
**P<0.01 for combination therapy VS corresponding dose of atorvastatin alone.
postal code no 03421
SKYPE ID poly.pharma/
Web site poly-pharma.com
Nexon Tab
TEL 82-2-352-8210 FAX 82-2-6280-4081 GSP 82-10-5008-1656
E-MAIL polypharm@gmail.com
Powerful inhibitor of gastric acid secretion

Efficacy
- High therapeutic effect with esomeprazole, the S-isomer of
omeprazole, as the main ingredient.
- Continuous inhibitory effect of esomeprazole on gastric acid
secretion due to its strong inhibitory effect on CYP2C19.
- Excellent efficacy on gastric acid-related diseases due to an
extended hypoacidity (pH > 4) retention period in the stomach,
compared to other PPI formulations.
- The S-isomer of omeprazole, esomeprazole, has higher blood
concentrations than omeprazole.
- Compared with other PPIs, esomeprazole had a higher
percentage of patients maintaining a gastric pH level of 4 or
Main Ingredients
higher.
Esomeprazole magnesium dihydrate 21.69mg
- Esomeprazole was more effective than omeprazole in treating
Esomeprazole magnesium dihydrate 43.38mg
heartburn.